Enhanced antiviral antibody secretion and attenuated immunopathology during influenza virus infection in nitric oxide synthase-2-deficient mice

Journal of General Virology

Volumn 87, Issue 11, 2006, Pages 3361-3371

  Jayasekera, Jerome P ^a,b   Vinuesa, Carola G ^c   Karupiah, Gunasegaran ^c   King, Nicholas J C ^b  

^a CENTER FOR BLOOD RESEARCH   (United States)

^b UNIVERSITY OF SYDNEY   (Australia)

^c Biology and Environment   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G2A ANTIBODY; MITOGENIC AGENT; NITRIC OXIDE SYNTHASE; VIRUS ANTIBODY;

ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; CELL MEDIATED CYTOTOXICITY; CELL STIMULATION; CONTROLLED STUDY; ENZYME DEFICIENCY; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INFECTION SENSITIVITY; INFLUENZA; INFLUENZA VIRUS A; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; MOUSE STRAIN; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; SYMPTOM; T LYMPHOCYTE; VIRUS LOAD; WILD TYPE;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; B-LYMPHOCYTES; CELLS, CULTURED; CYTOKINES; CYTOTOXICITY TESTS, IMMUNOLOGIC; IMMUNOGLOBULIN G; INFLUENZA A VIRUS; INTERFERON TYPE II; KILLER CELLS; LUNG; LYMPHOCYTE COUNT; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE II; ORTHOMYXOVIRIDAE INFECTIONS; PLASMA CELLS; SPLEEN; T-LYMPHOCYTES; VIRAL LOAD;

INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

EID: 33750253585     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.82131-0     Document Type: Article

References (57)

1. Adler, H., Beland, J. L., Del-Pan, N. C., Kobzik, L., Brewer, J. P., Martin, T. R. & Rimm, I. J. (1997). Suppression of herpes simplex virus type 1 (HSV-1)-induced pneumonia in mice by inhibition of inducible nitric oxide synthase (iNOS, NOS2). J Exp Med 185, 1533-1540.
2. Akaike, T., Noguchi, Y., Ijiri, S., Setoguchi, K., Suga, M., Zheng, Y. M., Dietzschold, B. & Maeda, H. (1996). Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals. Proc Natl Acad Sci U S A 93, 2448-2453.
3. Akaike, T., Okamoto, S., Sawa, T., Yoshitake, J., Tamura, F., Ichimori, K., Miyazaki, K., Sasamoto, K. & Maeda, H. (2003). 8-Nitroguanosine formation in viral pneumonia and its implication for pathogenesis. Proc Natl Acad Sci U S A 100, 685-690.
4. Bachmann, M. F. & Zinkernagel, R. M. (1996). The influence of virus structure on antibody responses and virus serotype formation. Immunol Today 17, 553-558.
5. Balázs, M., Martin, F., Zhou, T. & Kearney, J. F. (2002). Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity 17, 341-352.
6. Batten, M., Groom, J., Cachero, T. G., Qian, F., Schneider, P., Tschopp, J., Browning, J. L. & Mackay, F. (2000). BAFF mediates survival of peripheral immature B lymphocytes. J Exp Med 192, 1453-1466.
7. Baumgarth, N. & Kelso, A. (1996). in vivo blockade of gamma interferon affects the influenza virus-induced humoral and the local cellular immune response in lung tissue. J Virol 70, 4411-4418.
8. Beebe, D. P., Schreiber, R. D. & Cooper, N. R. (1983). Neutralization of influenza virus by normal human sera: mechanisms involving antibody and complement. J Immunol 130, 1317-1322.
9. Bender, B. S., Croghan, T., Zhang, L. & Small, P. A., Jr (1992). Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge. J Exp Med 175, 1143-1145.
10. Cerwenka, A., Morgan, T. M., Harmsen, A. G. & Dutton, R. W. (1999). Migration kinetics and final destination of type 1 and type 2 CD8 effector cells predict protection against pulmonary virus infection. J Exp Med 189, 423-434.
11. Conn, C. A., McClellan, J. L., Maassab, H. F., Smitka, C. W., Majde, J. A. & Kluger, M. J. (1995). Cytokines and the acute phase response to influenza virus in mice. Am J Physiol 268, R78-R84.
12. Coutelier, J.-P., van der Logt, J. T. M., Heessen, F. W. A., Warnier, G. & Van Snick, J. (1987). IgG2a restriction of murine antibodies elicited by viral infections. J Exp Med 165, 64-69.
13. + T cells. J Exp Med 174, 875-880.
14. Feng, J. O., Mozdzanowska, K. & Gerhard, W. (2002). Complement component C1q enhances the biological activity of influenza virus hemagglutinin-specific antibodies depending on their fine antigen specificity and heavy-chain isotype. J Virol 76, 1369-1378.
15. Fritz, R. S., Hayden, F. G., Calfee, D. P., Cass, L. M. r., Peng, A. W., Alvord, W. G., Strober, W. & Straus, S. E. (1999). Nasal cytokine and chemokine responses in experimental influenza A virus infection: results of a placebo-controlled trial of intravenous zanamivir treatment. J Infect Dis 180, 586-593.
16. Garthwaite, J. (1991). Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci 14, 60-67.
17. Graham, M. B., Dalton, D. K., Giltinan, D., Braciale, V. L., Stewart, T. A. & Braciale, T. J. (1993). Response to influenza infection in mice with a targeted disruption in the interferon γ gene. J Exp Med 178, 1725-1732.
18. Hasbold, J., Hong, J. S., Kehry, M. R. & Hodgkin, P. D. (1999). Integrating signals from IFN-γ and IL-4 by B cells: positive and negative effects on CD40 ligand-induced proliferation, survival, and division-linked isotype switching to IgG1, IgE, and IgG2a. J Immunol 163, 4175-4181.
19. Hayden, F. G., Fritz, R., Lobo, M. C., Alvord, W., Strober, W. & Straus, S. E. (1998). Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest 101, 643-649.
20. Iwasaki, T. & Nozima, T. (1977). Defense mechanisms against primary influenza virus infection in mice. I. The roles of interferon and neutralizing antibodies and thymus dependence of interferon and antibody production. J Immunol 118, 256-263.
21. 1. Virology 155, 625-632.
22. James, S. L., Cheever, A. W., Caspar, P. & Wynn, T. A. (1998). Inducible nitric oxide synthase-deficient mice develop enhanced type 1 cytokine-associated cellular and humoral immune responses after vaccination with attenuated Schistosoma mansoni cercariae but display partially reduced resistance. Infect Immun 66, 3510-3518.
23. Karupiah, G., Xie, Q. W., Buller, R. M., Nathan, C., Duarte, C. & MacMicking, J. D. (1993). Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science 261, 1445-1448.
24. Karupiah, G., Chen, J.-H., Mahalingam, S., Nathan, C. F. & MacMicking, J. D. (1998a). Rapid interferon γ-dependent clearance of influenza A virus and protection from consolidating pneumonitis in nitric oxide synthase 2-deficient mice. J Exp Med 188, 1541-1546.
25. Karupiah, G., Chen, J.-H., Nathan, C. F., Mahalingam, S. & MacMicking, J. D. (1998b). Identification of nitric oxide synthase 2 as an innate resistance locus against ectromelia virus infection. J Virol 72, 7703-7706.
26. Kipps, T. J., Parham, P., Punt, J. & Herzenberg, L. A. (1985). Importance of immunoglobulin isotype in human antibody-dependent, cell-mediated cytotoxicity directed by murine monoclonal antibodies. J Exp Med 161, 1-17.
27. Kobasa, D., Takada, A., Shinya, K & 16 other authors (2004). Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature 431, 703-707.
28. Kozak, W., Poli, V., Soszynski, D., Conn, C. A., Leon, L. R. & Kluger, M. J. (1997). Sickness behavior in mice deficient in interleukin-6 during turpentine abscess and influenza pneumonitis. Am J Physiol 272, R621-R630.
29. Lyons, A. B. & Parish, C. R. (1994). Determination of lymphocyte division by flow cytometry. J Immunol Methods 171, 131-137.
30. MacMicking, J. D., North, R. J., LaCourse, R., Mudgett, J. S., Shah, S. K. & Nathan, C. F. (1997). Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci U S A 94, 5243-5248.
31. Mellion, B. T., Ignarro, L. J., Ohlstein, E. H., Pontecorvo, E. G., Hyman, A. L. & Kadowitz, P. J. (1981). Evidence for the inhibitory role of guanosine 3′, 5′-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood 57, 946-955.
32. Michael, A., Hackett, J. J., Bennett, M., Kumar, V. & Yuan, D. (1989). Regulation of B lymphocytes by natural killer cells. Role of IFN-gamma. J Immunol 142, 1095-1101.
33. Moore, P. A., Belvedere, O., Orr, A. & 19 other authors (1999). BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 285, 260-263.
34. + T cells are ineffective in clearing a pulmonary infection with influenza type A virus in the absence of B cells. Virology 239, 217-225.
35. Nardelli, B., Belvedere, O., Roschke, V. & 8 other authors (2001). Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood 97, 198-204.
36. Neuberger, M. S. & Rajewsky, K. (1981). Activation of mouse complement by monoclonal mouse antibodies. Eur J Immunol 11, 1012-1016.
37. Noda, S., Tanaka, K., Sawamura, S. & 7 other authors (2001). Role of nitric oxide synthase type 2 in acute infection with murine cytomegalovirus. J Immunol 166, 3533-3541.
38. Palladino, G., Mozdzanowska, K., Washko, G. & Gerhard, W. (1995). Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice. J Virol 69, 2075-2081.
39. Palmer, R. M., Ferrige, A. G. & Moncada, S. (1987). Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327, 524-526.
40. Peper, R. L. & Van Campen, H. (1995). Tumor necrosis factor as a mediator of inflammation in influenza A viral pneumonia. Microb Pathog 19, 175-183.
41. Sarawar, S. R., Sangster, M., Coffman, R. L. & Doherty, P. C. (1994). Administration of anti-IFN-gamma antibody to beta 2-microglobulin-deficient mice delays influenza virus clearance but does not switch the response to a T helper cell 2 phenotype. J Immunol 153, 1246-1253.
42. Sato, K., Suga, M., Akaike, T., Fujii, S., Muranaka, H., Doi, T., Maeda, H. & Ando, M. (1998). Therapeutic effect of erythromycin on influenza virus-induced lung injury in mice. Am J Respir Crit Care Med 157, 853-857.
43. Saura, M., Zaragoza, C., McMillan, A., Quick R. A., Hohenadl, C., Lowenstein, J. M. & Lowenstein, C. J. (1999). An antiviral mechanism of nitric oxide: inhibition of a viral protease. Immunity 10, 21-28.
44. Schiltknecht, E. & Ada, G. L. (1985). In vivo effects of cyclosporine on influenza A virus-infected mice. Cell Immunol 91, 227-239.
45. Shtrichman, R. & Samuel, C. E. (2001). The role of gamma interferon in antimicrobial immunity. Curr Opin Microbiol 4, 251-259.
46. Snapper, C. M., Yamaguchi, H., Moorman, M. A. & Mond, J. J. (1994). An in vitro model for T cell-independent induction of humoral immunity. A requirement for NK cells. J Immunol 152, 4884-4892.
47. Stein-Streilein, J. & Guffee, J. (1986). In vivo treatment of mice and hamsters with antibodies to asialo GM1 increases morbidity and mortality to pulmonary influenza infection. J Immunol 136, 1435-1441.
48. Sullivan, J. L., Mayner, R. E., Barry, D. W. & Ennis, F. A. (1976). Influenza virus infection in nude mice. J Infect Dis 133, 91-94.
49. Swiergiel, A. H., Smagin, G. N., Johnson, L. J. & Dunn, A. J. (1997). The role of cytokines in the behavioral responses to endotoxin and influenza virus infection in mice: effects of acute and chronic administration of the interleukin-1-receptor antagonist (IL-lra). Brain Res 776, 96-104.
50. Szomolanyi-Tsuda, E. & Welsh, R. M. (1998). T-cell-independent antiviral antibody responses. Curr Opin Immunol 10, 431-435.
51. Takagi, K., Ae, S. & Suketa, Y. (1992). Effect of nitrite on cell growth and antibody production in mouse splenic B cells stimulated with lipopolysaccharide and B cell hybridomas. Chem Pharm Bull (Tokyo) 40, 419-422.
52. Takagi, K., Nukaya, I., Yasukawa, K. & Suketa, Y. (1994). Inhibitory mechanisms of antibody production by nitrogen oxides released from activated macrophages during the immune response: relationship to energy consumption. Immunol Cell Biol 72, 241-248.
53. Taylor-Robinson, A. W. (1997). Counter-regulation of T helper 1 cell proliferation by nitric oxide and interleukin-2. Biochem Biophys Res Commun 233, 14-19.
54. Topham, D. J., Tripp, R. A. & Doherty, P. C. (1997). CD8+ T cells clear influenza virus by perforin or Fas-dependent processes. J Immunol 159, 5197-5200.
55. Unkeless, J. C. & Eisen, H. N. (1975). Binding of monomeric immunoglobulins to Fc receptors of mouse macrophages. J Exp Med 142, 1520-1533.
56. Wall, D. A., Hamberg, S. D., Reynolds, D. S., Burakoff, S. J., Abbas, A. K. & Ferrara, J. L. (1988). Immunodeficiency in graft-versus-host disease. I. Mechanism of immune suppression. J Immunol 140, 2970-2976.
57. Zaragoza, C., Ocampo, C., Saura, M., Leppo, M., Well, X.-Q., Quick R., Moncada, S., Liew, F. Y. & Lowenstein, C. J. (1998). The role of inducible nitric oxide synthase in the host response to Coxsackievirus myocarditis. Proc Natl Acad Sci U S A 95, 2469-2474.